Valion Bio, Inc. Revenue Breakdown
No Revenue Breakdown for VBIO on this site yet.
- 2024-12-31: Others Not split by product in the filing$780.00K100.00%; Total revenue $780.00K.
- 2023-12-31: Others Not split by product in the filing$1.18M100.00%; Total revenue $1.18M.
- 2022-12-31: Others Not split by product in the filing$1.84M100.00%; Total revenue $1.84M.
- 2021-12-31: Others Not split by product in the filing$1.26M100.00%; Total revenue $1.26M.
Source checked: the stored Revenue Breakdown page for VBIO.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2024-12-31 | Not split by product in the filing $780.00K 100.00% | $780.00K |
| 2023-12-31 | Not split by product in the filing $1.18M 100.00% | $1.18M |
| 2022-12-31 | Not split by product in the filing $1.84M 100.00% | $1.84M |
| 2021-12-31 | Not split by product in the filing $1.26M 100.00% | $1.26M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2025-09-30 | Not split by product $146.00K 100.00% | $146.00K |
| 2025-06-30 | Not split by product $86.00K 100.00% | $86.00K |
| 2025-03-31 | Not split by product $70.00K 100.00% | $70.00K |
| 2024-12-31 | Not split by product $180.00K 100.00% | $180.00K |
| 2024-09-30 | Not split by product $126.00K 100.00% | $126.00K |
| 2024-06-30 | Not split by product $140.00K 100.00% | $140.00K |
| 2024-03-31 | Not split by product $334.00K 100.00% | $334.00K |
| 2023-12-31 | Not split by product $357.00K 100.00% | $357.00K |
| 2023-09-30 | Not split by product $282.00K 100.00% | $282.00K |
| 2023-06-30 | Not split by product $161.00K 100.00% | $161.00K |
| 2023-03-31 | Not split by product $376.00K 100.00% | $376.00K |
| 2022-12-31 | Not split by product $408.00K 100.00% | $408.00K |
| 2022-09-30 | Not split by product $477.00K 100.00% | $477.00K |
| 2022-06-30 | Not split by product $528.00K 100.00% | $528.00K |
| 2022-03-31 | Not split by product $428.00K 100.00% | $428.00K |
| 2021-12-31 | Not split by product $389.00K 100.00% | $389.00K |
| 2021-09-30 | Not split by product $277.00K 100.00% | $277.00K |
| 2021-06-30 | Not split by product $268.00K 100.00% | $268.00K |
| 2021-03-31 | Not split by product $323.00K 100.00% | $323.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |